| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |